BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Compounds That Target ULK2

unc-51 like autophagy activating kinase 2 · 19 compounds in BiohacksAI corpus

ULK2 (unc-51 like autophagy activating kinase 2) is a biological target with 19 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into ULK2 modulation for therapeutic and biohacking applications.

Most Studied Compounds for ULK2
298+
studies
298+
studies
All 19 Compounds — Ranked by Evidence
1
Alvocidib
4.52
confidence
2
Ruxolitinib
4.23
confidence
3
Bosutinib
4.08
confidence
4
Nintedanib
3.61
confidence
5
Tae 684
3.43
confidence
6
Fedratinib
3.40
confidence
7
Dovitinib
3.09
confidence
8
Lestaurtinib
3.04
confidence
9
R 406
2.83
confidence
10
Pha 665752
2.71
confidence
11
Kw 2449
2.64
confidence
12
Gsk 690693
2.64
confidence
13
Ast 487
2.56
confidence
14
Gsk 461364
2.40
confidence
15
Bx 795
2.40
confidence
16
Su 014813
2.20
confidence
17
Rebastinib
2.20
confidence
298+
studies
0.69
confidence
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for ULK2 (unc-51 like autophagy activating kinase 2). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: ULK2 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.